Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Europe allows exemption for medical CFCs :

This article was originally published in Clinica

Executive Summary

Continued exemptions for some medical applications are included in updated European legislation on ozone-depleting substances which has cleared its final stages in the European Parliament. A new regulation will allow national governments to permit the use of CFCs until December 31 2004 "in delivery mechanisms for hermetically sealed devices designed for implantation in the human body for delivery of measured doses of medication". The regulation will replace existing EU legislation on Europe's implementation of the Vienna convention for the protection of the ozone layer and the Montreal protocol on substances that deplete the ozone layer. The current 1994 regulation will be replaced by the new text on October 1. The regulation is directly binding and applies in all member states.

You may also be interested in...



UK Biotech Financing Holds Up Despite Woodford and Brexit

Neil Woodford’s fall from grace and Brexit dragged on an otherwise buoyant sector

Dr Reddy’s Focuses On India And China

Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.

Glenmark Sells Gynecology Unit

Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.

Topics

UsernamePublicRestriction

Register

MT076416

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel